Cardiotocography

From WikiMD's Wellness Encyclopedia

(Redirected from Cardiotocograph)

Cardiotocography

File:Cardiotocography sound.wav

Cardiotocography diagram
CTG Output

Cardiotocography (CTG) is a technical means of recording the fetal heartbeat and the uterine contractions during pregnancy, typically in the third trimester. It is a non-invasive method that utilizes ultrasound and a form of electrocardiography to create a fetal monitoring graph. This graph provides healthcare providers with valuable information about the fetal well-being and can help in making decisions regarding the management of the labor process.

Overview[edit | edit source]

Cardiotocography is primarily used in the antepartum period (before labor) for prenatal surveillance and during the intrapartum period (during labor) to monitor fetal well-being and to detect any signs of fetal distress. The procedure involves the placement of two transducers on the abdomen of a pregnant woman; one measures the fetal heart rate (FHR), while the other measures the uterine contractions.

Components[edit | edit source]

The main components of a CTG reading include:

  • Fetal Heart Rate (FHR): The normal baseline FHR ranges from 110 to 160 beats per minute. Variations from this range may indicate fetal distress or other conditions.
  • Uterine Contractions: Monitoring the frequency, duration, and intensity of uterine contractions helps in assessing the progress of labor.
  • Variability: This refers to the fluctuations in the FHR which are considered normal and indicate a healthy fetal autonomic nervous system.
  • Accelerations and Decelerations: Accelerations in FHR are usually a positive sign, while decelerations can be an indicator of potential problems, depending on their timing and pattern in relation to contractions.

Interpretation[edit | edit source]

The interpretation of CTG traces can be complex and requires training. The International Federation of Gynecology and Obstetrics (FIGO) has established guidelines for the interpretation of CTG. These guidelines categorize CTG traces into three tiers:

  • Normal (Reassuring): Indicates that the fetus is likely well-oxygenated and not in distress.
  • Intermediate (Non-reassuring): Suggests that closer monitoring or further tests are needed.
  • Abnormal (Pathological): Indicates a high likelihood of fetal distress, and immediate action may be required.

Clinical Use[edit | edit source]

Cardiotocography is widely used in both low-risk and high-risk pregnancies to monitor fetal health. In high-risk pregnancies, such as those involving gestational diabetes, pre-eclampsia, or intrauterine growth restriction (IUGR), CTG monitoring can be particularly valuable for early detection of potential problems.

Advantages and Disadvantages[edit | edit source]

The primary advantage of CTG is its ability to provide continuous, real-time monitoring of the fetus and the uterine contractions, allowing for timely interventions if necessary. However, its use has also been associated with an increase in cesarean section rates, possibly due to overinterpretation of fetal distress. Additionally, the specificity of CTG can be low, leading to false-positive results that may cause unnecessary interventions.

Conclusion[edit | edit source]

Cardiotocography has become an integral part of modern obstetric care, providing critical information that can help ensure the safety and well-being of both the mother and the fetus during pregnancy and labor. However, its interpretation requires expertise, and its use should be balanced with other forms of fetal and maternal assessment to guide clinical decisions effectively.


Contributors: Prab R. Tumpati, MD